Liquid Biopsy for Cancer Current Status and Future Challenges
Category: eBooks
- views: 96
- date: 21 January 2026
- posted by: BeMyLove
Liquid Biopsy for Cancer Current Status and Future Challenges | 7.05 MB
Title: Liquid Biopsy for Cancer
Author: Seung Il Kim, Young Kim
Category: Nonfiction, Health & Well Being, Medical, Specialties, Pathology, Oncology
Language: English | 134 Pages | ISBN: 9789819944187
Description:
Individual tumour molecular profiling and tracking dynamic evolution by treatment related selective pressure are crucial for clinical oncology. However, current tissue biopsy cannot represent spatial and temporal tumour heterogeneity due to sampling bias.
Liquid biopsy is an alternative way of tissue biopsy since it can represent comprehensive molecular signature from multiple distinct lesions and real time tracking is feasible by repeated longitudinal assay during course of treatment.
This book describes current knowledge regarding pre-analytical issues including standardization of blood preparation, analytical variability, clinical application and regulatory agency approval issue, etc. Regarding targets in circulation, it focuses on circulating tumour cells (CTCs), circulating nucleic acid (ctDNA, cell free RNAs), extracellular vesicles, tumour educated platelets, and others (proteins, metabolites).
The book will be a rich source of information and instruction for oncologists and offers stimulating ideas on prospects for further progress in this field.
The translation was done with the help of artificial intelligence. A subsequent human revision was done primarily in terms of content.
DOWNLOAD:
https://rapidgator.net/file/cfcf46f14e1dcbd99ec8ba35ec226bed/Liquid_Biopsy_for_Cancer_Current_Status_and_Future_Challenges.pdf
https://nitroflare.com/view/A2E726EEE8DCDC5/Liquid_Biopsy_for_Cancer_Current_Status_and_Future_Challenges.pdf
Individual tumour molecular profiling and tracking dynamic evolution by treatment related selective pressure are crucial for clinical oncology. However, current tissue biopsy cannot represent spatial and temporal tumour heterogeneity due to sampling bias.
Liquid biopsy is an alternative way of tissue biopsy since it can represent comprehensive molecular signature from multiple distinct lesions and real time tracking is feasible by repeated longitudinal assay during course of treatment.
This book describes current knowledge regarding pre-analytical issues including standardization of blood preparation, analytical variability, clinical application and regulatory agency approval issue, etc. Regarding targets in circulation, it focuses on circulating tumour cells (CTCs), circulating nucleic acid (ctDNA, cell free RNAs), extracellular vesicles, tumour educated platelets, and others (proteins, metabolites).
The book will be a rich source of information and instruction for oncologists and offers stimulating ideas on prospects for further progress in this field.
The translation was done with the help of artificial intelligence. A subsequent human revision was done primarily in terms of content.
DOWNLOAD:
https://rapidgator.net/file/cfcf46f14e1dcbd99ec8ba35ec226bed/Liquid_Biopsy_for_Cancer_Current_Status_and_Future_Challenges.pdf
https://nitroflare.com/view/A2E726EEE8DCDC5/Liquid_Biopsy_for_Cancer_Current_Status_and_Future_Challenges.pdf
We need your support!
Make a donation to help us stay online
Bitcoin (BTC)
bc1q08g9d22cxkawsjlf8etuek2pc9n2a3hs4cdrld
Bitcoin Cash (BCH)
qqvwexzhvgauxq2apgc4j0ewvcak6hh6lsnzmvtkem
Ethereum (ETH)
0xb55513D2c91A6e3c497621644ec99e206CDaf239
Litecoin (LTC)
ltc1qt6g2trfv9tjs4qj68sqc4uf0ukvc9jpnsyt59u
USDT (ERC20)
0xb55513D2c91A6e3c497621644ec99e206CDaf239
USDT (TRC20)
TYdPNrz7v1P9riWBWZ317oBgJueheGjATm
Information |
|||
 |
Users of GUESTS are not allowed to comment this publication. | ||